HomeAI · summaries
Storia in 6 fonti
Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earni
HIMS to release Q2 earnings on Aug. 10, expected to report a loss of 5 cents/share. FDA panel voted to add BPC-157 to compounding list. Stock rose 6.5% on Friday.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
markets.businessinsider.com
Hims & Hers Q2 Earnings Preview: Options Traders Brace for a 14.5% Move in HIMS Stock
Telehealth platform Hims & Hers Health (HIMS) will announce its second-quarter results on August 10. HIMS stock rose 6.5% to close at $31.59...
- ·
benzinga.com
Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earni
HIMS to release Q2 earnings on Aug. 10, expected to report a loss of 5 cents/share. FDA panel voted to add BPC-157 to compounding list. Stock rose 6.5% on Friday.
